The United States has doubled its investment—to nearly $1 billion—to expedite development of a potential COVID-19 vaccine by American firm Moderna, which on Monday begins the decisive final phase of clinical trials.
Jul 27, 2020
0
4
The US government has agreed to pay almost $2 billion for 100 million doses of a potential coronavirus vaccine, German firm BioNTech said on Wednesday.
Jul 22, 2020
0
1
French pharmaceutical giant Sanofi said Tuesday that it would invest $425 million to expand its vaccine development venture with US start-up Translate Bio as they aim to find a COVID-19 vaccine by next year.
Jun 23, 2020
0
2
A German biotech firm on Monday flatly denied newspaper reports that US president Donald Trump had offered to pay for exclusive rights to a coronavirus vaccine.
Mar 16, 2020
0
3
The US government and the Bill and Melinda Gates Foundation pledged Wednesday to jointly invest $200 million over the next four years to achieve affordable gene therapy-based cures for sickle cell disease (SCD) and HIV.
Oct 23, 2019
0
0
French pharmaceutical giant Sanofi said Monday that it initiated a probe into alleged bribery by company officials in the Middle East and Africa to healthcare workers.
Oct 7, 2014
0
0
The US law that extends health insurance coverage to most Americans, dubbed "Obamacare" by its detractors, is 2,400 pages long but only certain points have been challenged before the US Supreme Court.
Mar 23, 2012
0
0
GlaxoSmithKline said on Thursday it had agreed to pay $3.0 billion (2.2 billion euros) to settle long-running disputes with the US government over how the British pharmaceuticals group marketed and developed drugs.
Nov 3, 2011
0
0
The lack of financial assistance to cover the cost of drugs to Medicare beneficiaries (the US government's health insurance program for people aged 65 or over, which currently covers 50 million US citizens) could result in ...
Aug 16, 2011
3
0
